Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma

Kelly A. McNally, Jennifer Rohan, Mark Schluchter, Kristin Riekert, Pamela Vavrek, Amy Schmidt, Susan Redline, Carolyn Kercsmar, Dennis Drotar

Research output: Contribution to journalArticle

Abstract

High rates of asthma treatment nonadherence have been reported, particularly in economically disadvantaged African American youth. The relationship between adherence to combined medication treatment and asthma outcomes has potential clinical significance but is not well understood. Using electronic monitoring, we describe the pattern of adherence to daily corticosteroid (fluticasone) and leukotriene receptor antagonist (montelukast) medication over the course of 1 year in a population of African American youth with moderate to severe asthma. On average, adherence to montelukast was higher than adherence to fluticasone (p <0.01); however, for both medications, adherence rates significantly declined over the course of the study. After 1 year, participants took only 31 of prescribed doses of montelukast and 23 of prescribed doses of fluticasone. The decline in adherence to both fluticasone (p <0.05) and montelukast (p <0.001) was related to increased healthcare utilization. Furthermore, asthma symptom ratings were related montelukast (p <0.001), but not fluticasone adherence. These results suggest that adherence promotion intervention strategies are warranted to improve health-related outcomes in families who are at-risk for treatment nonadherence.

Original languageEnglish (US)
Pages (from-to)921-927
Number of pages7
JournalJournal of Asthma
Volume46
Issue number9
DOIs
StatePublished - Nov 5 2009

Fingerprint

montelukast
Vulnerable Populations
African Americans
Asthma
Leukotriene Antagonists
Therapeutics
Medication Adherence
Steroid Receptors
Fluticasone
Delivery of Health Care

Keywords

  • Compliance
  • Growth curve
  • Health care utilization
  • Pediatric asthma
  • Treatment adherence

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this

Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. / McNally, Kelly A.; Rohan, Jennifer; Schluchter, Mark; Riekert, Kristin; Vavrek, Pamela; Schmidt, Amy; Redline, Susan; Kercsmar, Carolyn; Drotar, Dennis.

In: Journal of Asthma, Vol. 46, No. 9, 05.11.2009, p. 921-927.

Research output: Contribution to journalArticle

McNally, KA, Rohan, J, Schluchter, M, Riekert, K, Vavrek, P, Schmidt, A, Redline, S, Kercsmar, C & Drotar, D 2009, 'Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma', Journal of Asthma, vol. 46, no. 9, pp. 921-927. https://doi.org/10.3109/02770900903229651
McNally, Kelly A. ; Rohan, Jennifer ; Schluchter, Mark ; Riekert, Kristin ; Vavrek, Pamela ; Schmidt, Amy ; Redline, Susan ; Kercsmar, Carolyn ; Drotar, Dennis. / Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. In: Journal of Asthma. 2009 ; Vol. 46, No. 9. pp. 921-927.
@article{c251ac8328e147f988da6e6bafaa3071,
title = "Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma",
abstract = "High rates of asthma treatment nonadherence have been reported, particularly in economically disadvantaged African American youth. The relationship between adherence to combined medication treatment and asthma outcomes has potential clinical significance but is not well understood. Using electronic monitoring, we describe the pattern of adherence to daily corticosteroid (fluticasone) and leukotriene receptor antagonist (montelukast) medication over the course of 1 year in a population of African American youth with moderate to severe asthma. On average, adherence to montelukast was higher than adherence to fluticasone (p <0.01); however, for both medications, adherence rates significantly declined over the course of the study. After 1 year, participants took only 31 of prescribed doses of montelukast and 23 of prescribed doses of fluticasone. The decline in adherence to both fluticasone (p <0.05) and montelukast (p <0.001) was related to increased healthcare utilization. Furthermore, asthma symptom ratings were related montelukast (p <0.001), but not fluticasone adherence. These results suggest that adherence promotion intervention strategies are warranted to improve health-related outcomes in families who are at-risk for treatment nonadherence.",
keywords = "Compliance, Growth curve, Health care utilization, Pediatric asthma, Treatment adherence",
author = "McNally, {Kelly A.} and Jennifer Rohan and Mark Schluchter and Kristin Riekert and Pamela Vavrek and Amy Schmidt and Susan Redline and Carolyn Kercsmar and Dennis Drotar",
year = "2009",
month = "11",
day = "5",
doi = "10.3109/02770900903229651",
language = "English (US)",
volume = "46",
pages = "921--927",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma

AU - McNally, Kelly A.

AU - Rohan, Jennifer

AU - Schluchter, Mark

AU - Riekert, Kristin

AU - Vavrek, Pamela

AU - Schmidt, Amy

AU - Redline, Susan

AU - Kercsmar, Carolyn

AU - Drotar, Dennis

PY - 2009/11/5

Y1 - 2009/11/5

N2 - High rates of asthma treatment nonadherence have been reported, particularly in economically disadvantaged African American youth. The relationship between adherence to combined medication treatment and asthma outcomes has potential clinical significance but is not well understood. Using electronic monitoring, we describe the pattern of adherence to daily corticosteroid (fluticasone) and leukotriene receptor antagonist (montelukast) medication over the course of 1 year in a population of African American youth with moderate to severe asthma. On average, adherence to montelukast was higher than adherence to fluticasone (p <0.01); however, for both medications, adherence rates significantly declined over the course of the study. After 1 year, participants took only 31 of prescribed doses of montelukast and 23 of prescribed doses of fluticasone. The decline in adherence to both fluticasone (p <0.05) and montelukast (p <0.001) was related to increased healthcare utilization. Furthermore, asthma symptom ratings were related montelukast (p <0.001), but not fluticasone adherence. These results suggest that adherence promotion intervention strategies are warranted to improve health-related outcomes in families who are at-risk for treatment nonadherence.

AB - High rates of asthma treatment nonadherence have been reported, particularly in economically disadvantaged African American youth. The relationship between adherence to combined medication treatment and asthma outcomes has potential clinical significance but is not well understood. Using electronic monitoring, we describe the pattern of adherence to daily corticosteroid (fluticasone) and leukotriene receptor antagonist (montelukast) medication over the course of 1 year in a population of African American youth with moderate to severe asthma. On average, adherence to montelukast was higher than adherence to fluticasone (p <0.01); however, for both medications, adherence rates significantly declined over the course of the study. After 1 year, participants took only 31 of prescribed doses of montelukast and 23 of prescribed doses of fluticasone. The decline in adherence to both fluticasone (p <0.05) and montelukast (p <0.001) was related to increased healthcare utilization. Furthermore, asthma symptom ratings were related montelukast (p <0.001), but not fluticasone adherence. These results suggest that adherence promotion intervention strategies are warranted to improve health-related outcomes in families who are at-risk for treatment nonadherence.

KW - Compliance

KW - Growth curve

KW - Health care utilization

KW - Pediatric asthma

KW - Treatment adherence

UR - http://www.scopus.com/inward/record.url?scp=70449632913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449632913&partnerID=8YFLogxK

U2 - 10.3109/02770900903229651

DO - 10.3109/02770900903229651

M3 - Article

VL - 46

SP - 921

EP - 927

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 9

ER -